Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parathyroid hormone type 1 receptor (PTH1R) is a class B G protein-coupled receptor that serves as the primary receptor for both parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP). It plays a central role in regulating blood calcium levels through actions in bone and kidney tissues. In bone, PTH1R stimulates osteoblasts to express RANKL, increasing bone resorption. In the kidney, it promotes calcium reabsorption and phosphate excretion. Mutations in *PTH1R* are associated with skeletal disorders. Agonists are used for osteoporosis management. Recent structural studies have clarified ligand binding and activation mechanisms, providing templates for drug design.
Agonists stimulate adenylyl cyclase via Gs, leading to increased cAMP production; can also activate phospholipase C via Gq; may have prolonged endosomal signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parathyroid Hormone Type 1 Receptor (PTH1R).